Boothbay Fund Management, LLC Aerie Pharmaceuticals Inc Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $258,622 - $618,338	40,600 New	40,600 $614,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $236,800 - $510,400	-20,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $132,031 - $187,020	7,451 Added 59.38%	20,000 $483,000
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $231,027 - $351,372	12,549 New	12,549 $241,000
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $165,000 - $300,200	-5,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $280,750 - $369,500	5,000 New	5,000 $308,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.